Bisphenol F induces nonalcoholic fatty liver disease-like changes: Involvement of lysosome disorder in lipid droplet deposition

Jun Wang,Pengfei Yu,Xuexue Xie,Linlin Wu,Manfei Zhou,Fei Huan,Lei Jiang,Rong Gao
DOI: https://doi.org/10.1016/j.envpol.2020.116304
IF: 8.9
2021-02-01
Environmental Pollution
Abstract:<p>Epidemiological studies have demonstrated that the general population's exposure to bisphenol A (BPA) substitutes is ubiquitous. Bisphenol F (BPF), one of the main BPA substitutes, is increasingly replacing BPA in plastics for food and beverage applications. Accumulating evidence suggests that BPA exposure is associated with nonalcoholic fatty liver disease (NAFLD)-like changes. However, the potential effects of BPF on lipid homeostasis remain poorly understood. In the present study, an epidemiological analysis with LC-MS-MS revealed that the BPF concentrations in the serum of NAFLD patients were significantly higher than those in a control group. Supporting this result, using Oil Red O, BODIPY 493/503, LipidTox Deep Red staining and gas chromatography-time-of-flight mass spectrometry (TOF-MS) assays, we found that BPF exposure induced NAFLD-like changes, with obvious lipid droplet deposition, triglyceride (TG) and fatty acids increase in mouse livers. Meanwhile, lipid droplet deposition and TG increase induced by BPF were also observed in HepG2 cells, accompanied by autophagic flux blockade, including autophagosome accumulation and the decreased degradation of SQSTM1/p62. Using adenoviruses dual-reporter plasmid RFP-GFP-LC3, RFP-GFP-PLIN2 transfection, AO staining, and EGFR degradation assays, we demonstrated that BPF treatment impaired lysosomal degradative capacity, since BPF treatment obviously impaired lysosomal acidification, manifested as decreased lysosomal hydrolase cathepsin L (CTSL) and mature cathepsin D (CTSD) in HepG2 and mouse liver issues. Additionally, v-ATPase D, a multi-subunit enzyme that mediates acidification of eukaryotic intracellular organelles, significantly decreased after BPF exposure in both the vitro and in vivo studies.</p><p>This study ascertained a novel mechanism involving dysfunctional of lysosomal degradative capacity induced by BPF, which contributes to lipophagic disorders and causes lipid droplet deposition. This work provides evidence that lysosomes may be a target organelle where BPF exerts its potential toxicity; therefore, novel intervention strategies targeting lysosome are promising for BPF-induced NAFLD-like changes.</p>
environmental sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the impact of bisphenol F (BPF) on non - alcoholic fatty liver disease (NAFLD) - like changes and its underlying mechanisms. Specifically, the research aims to: 1. **Evaluate the relationship between the internal exposure level of BPF and NAFLD patients**: By detecting the BPF concentration in the serum of NAFLD patients and healthy control groups, explore the association between BPF exposure and NAFLD. 2. **Verify whether BPF exposure will cause NAFLD - like changes in mice**: Through H&E staining, Oil Red O staining, and detecting the triglyceride (TG) and cholesterol levels in the mouse liver, observe the impact of BPF exposure on lipid deposition in the mouse liver. 3. **Explore the impact of BPF on lipid droplet deposition in in - vitro cell experiments**: Use the HepG2 cell line, evaluate the cytotoxicity of BPF by the CCK - 8 method, and detect lipid droplet deposition through BODIPY 493/503 and LipidTox Deep Red staining to further verify the impact of BPF on lipid accumulation. 4. **Study whether BPF exposure initiates the autophagy process**: By detecting the expression levels of autophagy - related genes and proteins, explore whether BPF exposure induces the occurrence of autophagy. 5. **Analyze the impact of BPF exposure on autophagosome - lysosome fusion**: Through immunofluorescence technology to detect the co - localization of Rab7 and LC3, evaluate the impact of BPF exposure on autophagosome - lysosome fusion. 6. **Reveal the mechanism by which BPF affects lysosome function**: By detecting the lysosome acidification ability, the expression levels of lysosomal hydrolases (such as cathepsin L and cathepsin D), and the expression of v - ATPase D, explore how BPF affects lysosome function, thereby leading to lipid droplet deposition. In summary, through multi - faceted experimental designs, this paper systematically explores the impact of BPF exposure on NAFLD - like changes and its underlying molecular mechanisms, especially the role of lysosomal dysfunction in it.